How Long Should You Take Spironolactone?

The length of time you should take spironolactone depends almost entirely on why you’re taking it. For acne, a typical course runs roughly one to two years, though many people stay on it longer. For heart failure, the drug is usually prescribed indefinitely. For conditions like hirsutism or polycystic ovary syndrome, doctors often recommend at least six to twelve months before evaluating results, and many patients remain on it for years. There is no single answer because spironolactone treats fundamentally different problems through a mix of overlapping mechanisms, and each condition has its own timeline for response, relapse, and risk.

Why the Reason You Take It Determines the Timeline

Spironolactone was originally developed as a blood pressure medication. It blocks a hormone called aldosterone that tells your kidneys to hold onto sodium and water, which raises blood pressure. But researchers discovered decades ago that spironolactone also blocks androgen receptors, essentially interfering with hormones like testosterone and its more potent cousin, dihydrotestosterone, at the tissue level.¹ That dual action means the drug ended up being prescribed for a surprisingly wide range of conditions: stubborn acne, excess facial hair growth, heart failure, resistant high blood pressure, and as part of feminizing hormone therapy for transgender women.

Each of those conditions responds on a different schedule, and the consequences of stopping vary. A heart failure patient who discontinues spironolactone faces a measurably higher risk of dying. A person using it for acne may see breakouts return within months, or may find the improvement lasts well beyond the last pill. Understanding these differences is the key to knowing how long your course should be.

Duration for Acne

Most dermatologists prescribe spironolactone for acne in women as a medium- to long-term treatment, not a quick fix. A large case series of 403 women found that the average time patients stayed on the drug was roughly 470 days, or about 15 to 16 months.² By the first follow-up, about three-quarters of patients saw a meaningful reduction or complete clearance of facial acne, with similarly high improvement rates on the chest and back.

The catch is that spironolactone doesn’t cure the hormonal drivers of acne. It suppresses them for as long as you take it. Many people start seeing results within three months, but the full effect can take six months or longer. Some dermatologists will try tapering the dose after a year or two of clear skin, dropping from a typical 100 mg daily to 50 mg or even 25 mg, to see if a lower dose maintains the benefit. Others prefer to keep patients at whatever dose produced clearance, especially if the acne was severe. There’s no universally agreed-upon stopping point.

What makes this decision tricky is what happens after you stop.

What Happens When You Discontinue

For hormonal conditions like acne and hirsutism, stopping spironolactone often means the problem comes back, though not always. A study tracking patients with hyperandrogenic skin disorders found that about two-thirds of them still had prolonged benefit roughly 34 months after discontinuing the drug, while the remaining third relapsed at an average of about 17 and a half months after stopping.³ Interestingly, the researchers couldn’t find a reliable clinical or biochemical marker that predicted who would relapse and who wouldn’t. Women with ovulatory-pattern polycystic ovary syndrome tended to relapse earlier than those with the classic form, suggesting the underlying hormonal profile matters, but there was no simple blood test to tell you in advance.

This unpredictability is why many prescribers take a “try tapering and see” approach. If your skin stays clear for several months on a reduced dose, you might be a good candidate for stopping altogether. If breakouts return quickly, going back to the effective dose is straightforward. The drug doesn’t lose effectiveness with repeated use.

Duration for Hirsutism and PCOS

For women dealing with unwanted facial or body hair growth, the timeline looks a bit different from acne. Hair growth cycles are slow, so it takes longer to see results. In clinical trials, regression of hirsutism, measured by hair diameter, density, and growth rate, became noticeable within about two months, but the maximum effect wasn’t reached until six months. That benefit was maintained at twelve months, and the drug worked equally well whether the hirsutism was linked to polycystic ovary syndrome or had no identifiable hormonal cause.⁴

Because of that slow response curve, doctors typically recommend committing to at least six to twelve months before judging whether the drug is working. Many women stay on spironolactone for years for this indication, especially if hair growth returns after stopping. Unlike acne, where some people enjoy lasting remission after discontinuation, hirsutism tends to come back more reliably when the antiandrogen effect is removed, because the hair follicles themselves haven’t changed. You’re just taking away the hormonal signal that was stimulating them.

Duration for Heart Failure

When spironolactone is prescribed for heart failure, the expected duration is usually the rest of your life. The landmark RALES trial, which studied patients with severe heart failure, was stopped early because the benefit was so clear: death rates dropped by about 30% in the spironolactone group compared to placebo after an average follow-up of two years.⁵ That reduction came from fewer deaths due to both progressive heart failure and sudden cardiac death.

A later propensity-matched study confirmed that the survival benefit extended even to patients with reduced kidney function, a group often excluded from clinical trials. After two years, 84% of patients taking spironolactone were alive, compared to 73% of those not taking it.⁶ Given these numbers, stopping the medication in heart failure is generally only considered when side effects become intolerable or kidney function deteriorates significantly.

Duration for Resistant Hypertension

If you’re taking spironolactone because your blood pressure doesn’t respond adequately to other medications, the duration is similarly open-ended. In patients with resistant hypertension, even low-dose spironolactone produced an additional average blood pressure drop of about 25/12 mmHg at six months, on top of whatever other blood pressure drugs they were already taking.⁷ That’s a substantial reduction. The effect was consistent regardless of whether the patient had an identifiable aldosterone-producing tumor or not, meaning the drug works broadly across the spectrum of hard-to-treat high blood pressure.

Since the blood pressure benefit only lasts while you’re taking the drug, stopping it means your blood pressure will rise again. For most people with resistant hypertension, spironolactone becomes a permanent part of their medication regimen unless another drug can take over its role or the underlying cause is corrected surgically.

Duration in Gender-Affirming Hormone Therapy

Transgender women who use spironolactone as an antiandrogen alongside estrogen typically take it for years. One study from a US endocrinology clinic found that patients starting feminizing hormone therapy required about nine months to reach a steady-state testosterone level, with significant variation in how much suppression each person achieved. The top quartile of responders reliably reached testosterone levels in the typical female range, while roughly a quarter of patients couldn’t achieve meaningful suppression at all.⁸

For those who respond well, spironolactone is continued as long as testosterone suppression is desired. Some people eventually transition to other antiandrogens or to estrogen monotherapy, particularly if they undergo gonadectomy, which removes the body’s primary source of testosterone. But for many transgender women, spironolactone remains part of their regimen for years or decades.

Potassium and Kidney Risks Over Time

The most important safety concern with long-term spironolactone use is elevated potassium, because the drug’s basic mechanism involves telling your kidneys to retain potassium instead of excreting it. In a study of patients with chronic kidney disease, those taking spironolactone had roughly three times the rate of hospitalizations for dangerously high potassium compared to non-users, and higher doses carried higher risk.⁹

That sounds alarming, but context matters enormously. An analysis of adverse events reported to the FDA for women of all ages found that while hyperkalemia was the most commonly reported side effect (about 16% of all reports), the age distribution was extremely skewed. Among women aged 18 to 45, the age range most likely to be taking spironolactone for acne or hirsutism, hyperkalemia cases accounted for just 1% of reports. The overwhelming majority of cases occurred in women over 65, who were more likely taking the drug for heart failure or hypertension and who typically had age-related kidney decline.¹⁰

This is why the monitoring schedule differs depending on who you are. If you’re a young, otherwise healthy woman taking spironolactone for acne, many dermatologists check your potassium once or twice early on and then stop routine blood draws if levels are normal. If you’re an older adult with heart failure or kidney issues, potassium monitoring is far more frequent and the stakes of getting it wrong are higher.

The Combination That Increases Risk

The potassium concern amplifies when spironolactone is combined with certain other medications, particularly ACE inhibitors and angiotensin receptor blockers, both commonly prescribed for heart failure and high blood pressure. A population-based study found that heart failure patients taking spironolactone alongside these drugs had dramatically higher odds of developing dangerous potassium levels, with an odds ratio above 13 compared to those not on spironolactone.¹¹ In clinical trials, this combination is managed carefully with regular blood tests. In the real world, monitoring sometimes falls through the cracks, which is why some of the worst outcomes happen outside of closely supervised settings.

If you’re taking spironolactone for a dermatologic reason and aren’t on any of these other medications, your risk profile is fundamentally different from a heart failure patient on three or four cardiovascular drugs. That distinction matters when deciding how long to continue treatment and how worried to be about side effects.

The Breast Cancer Question

Because spironolactone has hormonal effects, a reasonable concern for people taking it long-term is whether it increases cancer risk, particularly breast cancer. This was a bigger worry decades ago, after rodent studies showed tumor growth at very high doses. But the human data has been reassuring. A systematic review and meta-analysis of three studies found no statistically significant association between spironolactone use and breast cancer risk.¹²

A separate matched cohort study specifically looking at women older than 55 with no history of breast cancer found a hazard ratio of essentially 1.0, meaning spironolactone users developed breast cancer at the same rate as non-users over long follow-up periods.¹³ Another study examined whether the drug affected breast cancer recurrence in women who had already been diagnosed. It also found no increased risk of recurrence.¹⁴

This doesn’t mean the question is closed forever; the meta-analysis authors noted that the certainty of evidence was very low, partly because the studies involved different populations and used different methods. But for a woman deciding whether to stay on spironolactone for years, the existing evidence does not support breast cancer as a practical reason to stop.

Pregnancy and When You Must Stop

One situation where you absolutely must stop spironolactone is if you become pregnant or are planning to become pregnant. Because the drug blocks androgen receptors, it can interfere with the normal sexual development of a male fetus, potentially causing feminization of the genitalia.¹⁵ This risk is well-established in animal studies and is the reason spironolactone carries a strong pregnancy warning. If you’re sexually active and could become pregnant, reliable contraception is considered essential while on the drug. Many prescribers pair spironolactone with a combined oral contraceptive pill for this reason, which also has the side benefit of reducing menstrual irregularity, a common nuisance side effect.

Why People Stop Before They Should

Understanding how long you should take spironolactone is one thing; actually staying on it is another. In heart failure patients, treatment adherence with spironolactone was significantly lower than with other standard heart failure drugs like ACE inhibitors and beta-blockers, whether measured at three months, six months, or a year.¹⁶ A separate study found that about a third of heart failure patients who started spironolactone discontinued it due to side effects after an average of roughly eleven months. The most common reasons were elevated potassium or creatinine levels, which led doctors to stop the drug in about one in five treatment courses.¹⁷

For dermatologic uses, the dropout reasons tend to be different: breast tenderness, irregular periods, fatigue, or simply frustration during the slow weeks before results appear. The patients in the 403-person acne series who used combined oral contraceptives alongside spironolactone were far less likely to experience menstrual side effects, with roughly one-quarter the odds of menstrual problems compared to those not on the pill.² If side effects are the reason you’re considering stopping early, adjusting the dose or adding a companion medication may be a better first step than quitting.

Topical Spironolactone as a Way Around the Duration Question

One development that could change the conversation about treatment duration is topical spironolactone. Researchers have been working on cream and gel formulations that deliver the antiandrogen effect directly to the skin while minimizing the systemic exposure that causes side effects like elevated potassium and menstrual changes.¹⁸ A topical version with fewer systemic effects could, in theory, make long-term or even indefinite use much more acceptable for people treating acne or other skin conditions. The research is still in its early stages, with pilot studies and small trials, but a topical formulation is already marketed in some countries. Whether it works well enough to replace oral spironolactone for moderate-to-severe acne remains to be seen, though initial results for mild cases have been promising.